Fig. 3From: A multicenter, randomized study of decitabine as epigenetic priming with induction chemotherapy in children with AMLOverlap of differentially methylated loci between arms and time points in Arm A (DADE), Arm B (ADE), and screening vs. recovery marrow aspirates. Screening marrows for samples in Arm A and Arm B are also compared and demonstrate little intrinsic bias between groupsBack to article page